Drug intelligence / Profile preview

methylcobalamin + nortriptyline + pregabalin (Rivchem Pharmaceuticals)

Development stage
Unknown
Lead developer
Rivchem Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

NEURO RIV NT is a fixed-dose combination sustained-release tablet developed by Rivchem Pharmaceuticals for the management of neuropathic pain, such as diabetic neuropathy, postherpetic neuralgia, and spinal cord injury. The formulation combines three active ingredients with complementary mechanisms: pregabalin, nortriptyline, and methylcobalamin. Pregabalin is an alpha-2-delta ligand that binds to voltage-gated calcium channels in the central nervous system, reducing calcium influx and the subsequent release of excitatory neurotransmitters. Nortriptyline is a tricyclic antidepressant that inhibits the reuptake of norepinephrine and serotonin, thereby enhancing descending inhibitory pain pathways. Methylcobalamin, an active coenzyme form of vitamin B12, acts as a cofactor for methionine synthase, promoting myelin sheath synthesis, axonal regeneration, and nerve repair.

Brand names
Neuro Riv NTNeuro Riv NT Tablet SRNeuro Riv NT Tablets
Other names
methylcobalamin + nortriptyline + pregabalinpregabalin + nortriptyline + methylcobalamin
02

Targets

MTR (Methionine synthase)SERT (Sodium-dependent serotonin transporter)NET (Norepinephrine Transporter)α2δ (Voltage-gated calcium channel alpha-2-delta subunit)CACNA2D1 (Voltage-gated calcium channel subunit alpha2/delta-1)

Beyond the preview

Go deeper on methylcobalamin + nortriptyline + pregabalin (Rivchem Pharmaceuticals).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylcobalamin + nortriptyline + pregabalin (Rivchem Pharmaceuticals).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call